Cellular transplantation approaches for repair of the injured spinal cord: Ongoing and pending clinical trials

Topics in Spinal Cord Injury Rehabilitation

Volumn 14, Issue 4, 2009, Pages 47-61

  Hawryluk, Gregory W J ^a   Fehlings, Michael G ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Clinical trials; Pathophysiology; Spinal cord injury; Translational research

Indexed keywords

GACYCLIDINE; GANGLIOSIDE GM1; METHYLPREDNISOLONE SODIUM SUCCINATE; NIMODIPINE; PLACEBO; PROTIRELIN DERIVATIVE;

CELL REGENERATION; CELL TRANSPLANTATION; CELL TYPE; CLINICAL TRIAL; CYTOLOGY; DRUG MEGADOSE; HEMATOPOIETIC STEM CELL; HUMAN; LOW DRUG DOSE; NERVE CELL; OLFACTORY ENSHEATHING CELL; PATHOPHYSIOLOGY; REMYELINIZATION; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; STEM CELL;

EID: 67651083830     PISSN: 10820744     EISSN: None     Source Type: Journal    
DOI: 10.1310/sci1404-47     Document Type: Review

References (91)

1. Baptiste DC, Fehlings MG. Pharmacological approaches to repair the injured spinal cord. J Neurotrauma. 2006;23:318-334. (Pubitemid 43726313)
2. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J. 2004;4:451-464. (Pubitemid 38992289)
3. Lammertse DP. Update on pharmaceutical trials in acute spinal cord injury. J Spinal Cord Med. 2004;27:319-325. (Pubitemid 44132771)
4. Tator CH. Review of treatment trials in human spinal cord injury: Issues, difficulties, and recommendations. Neurosurgery. 2006;59:957-982. (Pubitemid 44852056)
5. Bracken MB, Shepard MJ, Collins WF, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322:1405-1411.
6. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care. J Neurosurg. 2000; 93:1-7. (Pubitemid 30457375)
7. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of the injured spinal cord: A review of completed, ongoing, and planned clinical trials for acute spinal cord injury. Neurosurg Focus. 2008;25:E14.
8. Hawryluk GW, Fehlings MG. The center of the spinal cord may be central to its repair. Cell Stem Cell. 2008;3:230-232.
9. Sullivan PG, Rabchevsky AG, Waldmeier PC, Springer JE. Mitochondrial permeability transition in CNS trauma: Cause or effect of neuronal cell death? J Neurosci Res. 2005;79:231-239.
10. Balentine J. Pathology of experimental spinal cord trauma. I. The necrotic lesion as a function of vascular injury. Lab Invest. 1978;39:236-253. (Pubitemid 9003898)
11. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma. 2006;23:264-280. (Pubitemid 43726309)
12. Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: A novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res. 2002;137:177-190. (Pubitemid 35460945)
13. Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery. 1999;44:1027-1039.
14. Mautes AE, Weinzierl MR, Donovan F, Noble LJ. Vascular events after spinal cord injury: Contribution to secondary pathogenesis. Phys Ther. 2000;80:673-687. (Pubitemid 30441697)
15. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg. 1991;75:15-26.
16. Buss A, Schwab ME. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia. 2003;42:424-432. (Pubitemid 36702283)
17. Casha S, Yu WR, Fehlings MG. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience. 2001;103:203-218. (Pubitemid 32304360)
18. Ackery A, Robbins S, Fehlings MG. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma. 2006; 23:604-616. (Pubitemid 43728050)
19. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: A review with an emphasis on the implications for white matter degeneration. J Neurotrauma. 2004;21:754-774. (Pubitemid 38880247)
20. Popovich, PG. Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res. 2000;128:43-58. (Pubitemid 35461225)
21. McCord JM, Edeas MA. SOD, oxidative stress and human pathologies: A brief history and a future vision. Biomed Pharmacother. 2005;59:139-142.
22. Pehar M, Vargas MR, Robinson KM, et al. Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radic Biol Med. 2006;41:1632-1644. (Pubitemid 44634237)
23. Dumont AS, Dumont RJ, Oskouian RJ. Will improved understanding of the pathophysiological mechanisms involved in acute spinal cord injury improve the potential for therapeutic intervention? Curr Opin Neurol. 2002;15:713-720
24. Jacobs WB, Fehlings MG. The molecular basis of neural regeneration. Neurosurgery. 2003; 53:943-948.
25. Caroni P, Schwab ME. Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol. 1988; 106:1281-1288. (Pubitemid 18131083)
26. Caroni P, Schwab ME. Antibody against myelin- associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988;1:85-96.
27. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J. Regeneration of adult axons in white matter tracts of the central nervous system. Nature. 1997; 390:680-683. (Pubitemid 28016354)
28. Hofstetter CP, Holmström NA, Lilja JA, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci. 2005;8:346-353.
29. Macias MY, Syring MB, Pizzi MA, Crowe MJ, Alexanian AR, Kurpad SN. Pain with no gain: Allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol. 2006;201:335-348. (Pubitemid 44344226)
30. Fehlings M, Tator CH. The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp Neurol. 1995;132:220-228.
31. Nashmi R, Fehlings MG. Changes in axonal physiology and morphology after chronic compressive injury of the rat thoracic spinal cord. Neuroscience. 2001;104:235-251. (Pubitemid 32322628)
32. Karimi-Abdolrezaee S, Eftekharpour E, Fehlings MG. Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: Implications for axonal pathophysiology after neurotrauma. Eur J Neurosci. 2004;19:577-589. (Pubitemid 38241297)
33. Pearse DD, Sanchez AR, Pereira FC, et al. Transplantation of Schwann cells and/or olfactory ensheathing glia into the contused spinal cord: Survival, migration, axon association, and functional recovery. Glia. 2007;55:976-1000.
34. Ogawa Y, Sawamoto K, Miyata T, et al. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J Neurosci Res. 2002;69:925-933. (Pubitemid 34984709)
35. Okano H, Ogawa Y, Nakamura M, Kaneko S, Iwanami A, Toyama Y. Transplantation of neural stem cells into the spinal cord after injury. Semin Cell Dev Biol. 2003;14:191-198. (Pubitemid 38160914)
36. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Morshead CM, Fehlings MG. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J Neurosci. 2006;26:3377-3389.
37. Eftekharpour E, Karimi S, Wang J, El Beheiry H, Morshead C, Fehlings MG. Myelination of congenitally dysmyelinated spinal cord axons by adult neural precursor cells results in formation of nodes of Ranvier and improved axonal conduction. J Neurosci. 2007;27:3416-3428. (Pubitemid 46515125)
38. Enzmann GU, Benton RL, Talbott J, Cao Q, Whittemore SR. Functional considerations of stem cell transplantation therapy for spinal cord repair. J Neurotrauma. 2006;23:479-495. (Pubitemid 43726323)
39. Koshizuka S, Okada S, Okawa A, et al. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol. 2004;63:64-72. (Pubitemid 38030234)
40. Ohta M, Suzuki Y, Noda T, et al. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol. 2004;187:266-278. (Pubitemid 38610273)
41. Wu S, Suzuki Y, Ejiri Y, et al. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J Neurosci Res. 2003;72:343-351. (Pubitemid 36504703)
42. Lladó J, Haenggeli C, Maragakis NJ, Snyder EY, Rothstein JD. Neural stem cells protect against glutamate-induced excitotoxicity and promote survival of injured motor neurons through the secretion of neurotrophic factors. Mol Cell Neurosci. 2004;27:322-331. (Pubitemid 39433844)
43. Lu P, Jones LL, Snyder EY, Tuszynski MH. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol. 2003;181:115-129. (Pubitemid 36629234)
44. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003;422:688-694. (Pubitemid 36514101)
45. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: Promise on the horizon. Neurosurg Focus. 2008;25:E2.
46. van der Kooy D, Weiss S. Why stem cells? Science. 2000;287:1439-1441. (Pubitemid 30127129)
47. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science. 1992;255:1707-1710.
48. Weiss S, Dunne C, Hewson J, Wohl, C, Wheatley M, Peterson AC, Reynolds BA. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J Neurosci. 1996;16:7599-7609. (Pubitemid 26389699)
49. Martens DJ, Tropepe V, van Der Kooy D. Separate proliferation kinetics of fibroblast growth factor-responsive and epidermal growth factor- responsive neural stem cells within the embryonic forebrain germinal zone. J Neurosci. 2000;20:1085-1095. (Pubitemid 30220466)
50. Yamamoto S, Yamamoto N, Kitamura T, Nakamura K, Nakafuku M. Proliferation of parenchymal neural progenitors in response to injury in the adult rat spinal cord. Exp Neurol. 2001;172:115-127. (Pubitemid 33141159)
51. Nistor GI, Totoiu MO, Haque N, Carpenter MK, Keirstead HS. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia. 2005;49:385-396. (Pubitemid 40222916)
52. Park IH, Zhao R, West JA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141-146.
53. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell. 2007;1:55-70.
54. Nakagawa M, Koyanagi M, Tanabe K, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol. 2008;26:101-106.
55. Dobkin BH, Curt A, Guest J. Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil Neural Repair. 2006;20:5-13. (Pubitemid 43214453)
56. Steeves JD, Fawcett JW, Tuszynski MH, et al. Experimental treatments for spinal cord injury: What you should know if you are considering participation in a clinical trial. Vancouver, BC: International Campaign for Cures of Spinal Cord Injury Paralysis; 2007 Available at: http://www.icord.org/ICCP/ Experimental-treatment-for-SCIsummary-nc.pdf
57. Cesaro, P. The design of clinical trials for cell transplantation into the central nervous system. NeuroRx. 2004;1:492-499. (Pubitemid 46591889)
58. Sagen J. Cellular therapies for spinal cord injury: What will the FDA need to approve moving from the laboratory to the human? J Rehabil Res Dev. 2003;40:71-79. (Pubitemid 36988682)
59. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci. 2005;25:4694-4705. (Pubitemid 40664118)
60. Lebkowski JS, Gold J, Xu C, Funk W, Chiu CP, Carpenter MK. Human embryonic stem cells: Culture, differentiation, and genetic modification for regenerative medicine applications. Cancer J. 2001;7:S83-93.
61. Vogel, G. Cell biology. Ready or not? Human ES cells head toward the clinic. Science. 2005; 308:1534-1538
62. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science. 1981;214:931-933.
63. Toma JG, Akhavan M, Fernandes KJ, Barnabé- Heider F, Sadikot A, Kaplan DR, Miller FD. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol. 2001;3:778-784. (Pubitemid 32842682)
64. Toma JG, McKenzie IA, Bagli D, Miller FD. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells. 2005;23:727-737. (Pubitemid 40791788)
65. Bunge, RP. Schwann cells in central regeneration. Ann NY Acad Sci. 1991;633:229-233.
66. Golden KL, Pearse DD, Blits B, Garg MS, Oudega M, Wood PM, Bunge MB. Transduced Schwann cells promote axon growth and myelination after spinal cord injury. Exp Neurol. 2007;207:203-217. (Pubitemid 47429655)
67. Pinzon A, Calancie B, Oudega M, Noga BR. Conduction of impulses by axons regenerated in a Schwann cell graft in the transected adult rat thoracic spinal cord. J Neurosci Res. 2001;64:533-541. (Pubitemid 32521773)
68. Xu XM, Guénard V, Kleitman N, Bunge MB. Axonal regeneration into Schwann cellseeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol. 1995;351:145-160
69. Raisman G, Li Y. Repair of neural pathways by olfactory ensheathing cells. Nat Rev Neurosci. 2007;8:312-319. (Pubitemid 46452322)
70. Ramón-Cueto A, Cordero MI, Santos-Benito FF, Avila J. Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron. 2000;25:425-435. (Pubitemid 30831796)
71. Ramón-Cueto A, Plant GW, Avila J, Bunge MB. Long-distance axonal regeneration in the transected adult rat spinal cord is promoted by olfactory ensheathing glia transplants. J Neurosci. 1998;18:3803-3815. (Pubitemid 28225687)
72. Richter MW, Roskams AJ. Olfactory ensheathing cell transplantation following spinal cord injury: Hype or hope? Exp Neurol. 2008;209:353-367. (Pubitemid 351174130)
73. Boyd JG, Doucette R, Kawaja MD. Defining the role of olfactory ensheathing cells in facilitating axon remyelination following damage to the spinal cord. FASEB J. 2005;19:694-703. (Pubitemid 40617374)
74. Boyd JG, Skihar V, Kawaja M, Doucette R. Olfactory ensheathing cells: Historical perspective and therapeutic potential. Anat Rec B New Anat. 2003;271:49-60. (Pubitemid 37248094)
75. Devon R, Doucette R. Olfactory ensheathing cells myelinate dorsal root ganglion neurites. Brain Res. 1992;589:175-179.
76. Lima C, Pratas-Vital J, Escada P, Hasse-Ferreira A, Capucho C, Peduzzi JD. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spinal Cord Med. 2006;29:191-203.
77. Féron F, Perry C, Cochrane J, Licina P, Nowitzke A, Urquhart S, et al. Autologous olfactory ensheathing cell transplantation in human spinal cord injury. Brain. 2005;128:2951-2960. (Pubitemid 41746648)
78. Guest J, Herrera LP, Qian T. Rapid recovery of segmental neurological function in a tetraplegic patient following transplantation of fetal olfactory bulb-derived cells. Spinal Cord. 2006;44:135-142. (Pubitemid 43348373)
79. Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. J Exp Med. 1987;165:1218-1223. (Pubitemid 17064518)
80. Rapalino O, Lazarov-Spiegler O, Agranov E, et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998;4:814-821. (Pubitemid 28331023)
81. Knoller N, Auerbach G, Fulga V, et al. Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: Phase I study results. J Neurosurg Spine. 2005;3:173-181.
82. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells. 2007;25:2896-2902.
83. Parr AM, Tator CH, Keating A. Bone marrowderived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplant. 2007;40:609-619. (Pubitemid 47456475)
84. Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH, Park HS. Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. Tissue Eng. 2005;11:913-922. (Pubitemid 40960794)
85. Yoon SH, Shim YS, Park YH, et al. Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells. 2007;25:2066-2073.
86. Syková E, Homola A, Mazanec R, et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant. 2006;15:675-687. (Pubitemid 46095251)
87. Rabinovich SS, Seledtsov VI, Poveschenko OV, et al. Transplantation treatment of spinal cord injury patients. Biomed Pharmacother. 2003;57:428-433. (Pubitemid 37494718)
88. Lammertse D, Tuszynski MH, Steeves JD, et al, International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: Clinical trial design. Spinal Cord. 2007;45:232-242. (Pubitemid 46340850)
89. Fawcett JW, Curt A, Steeves JD, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: Spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials. Spinal Cord. 2007;45:190-205. (Pubitemid 46340848)
90. Steeves JD, Lammertse D, Curt A, et al, International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP Panel: Clinical trial outcome measures. Spinal Cord. 2007;45:206-221. (Pubitemid 46340850)
91. Tuszynski MH, Steeves JD, Fawcett JW, et al, International Campaign for Cures of Spinal Cord Injury Paralysis. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: Clinical trial inclusion/exclusion criteria and ethics. Spinal Cord. 2007;45:222-231.